A patient with schizophrenia is prescribed clozapine. What should the nurse monitor for as the most serious potential adverse effect?

Choice A reason: While tardive dyskinesia is a serious concern with many antipsychotics, clozapine is actually associated with a very low risk of this condition. In fact, clozapine is often used as a treatment strategy for patients who have already developed severe tardive dyskinesia from other neuroleptic medications. Choice B reason: Clozapine has a unique pharmacological profile with low D2 receptor occupancy in the striatum, making extrapyramidal symptoms like tremors or rigidity highly unlikely. It is specifically chosen for patients who are treatment-resistant or highly sensitive to the motor side effects caused by other typical or atypical antipsychotics. Choice C reason: Serotonin syndrome is a toxic state caused by excessive serotonergic activity, usually resulting from interactions between SSRIs, SNRIs, or MAOIs. While clozapine affects various neurotransmitter systems, it is not primarily associated with the development of serotonin syndrome, which presents with hyperreflexia, clonus, and autonomic instability. Choice D reason: Agranulocytosis is a life-threatening reduction in the white blood cell count (specifically neutrophils) that can occur in patients taking clozapine. This requires strict mandatory blood monitoring of the Absolute Neutrophil Count (ANC) to prevent severe sepsis or death, making it the most critical safety priority for the nurse.